Infinity Pharmaceuticals (NASDAQ:INFI) Receives New Coverage from Analysts at Truist Financial

Retrieved on: 2021-03-17 13:16:37

Tags for this article:

Click the tags to see associated articles and topics

Infinity Pharmaceuticals (NASDAQ:INFI) Receives New Coverage from Analysts at Truist Financial. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 2,215,974 shares of the biotechnology company's stock valued at $4,698,000 after purchasing an additional ...

Article found on: www.marketbeat.com